Assessment of SARS-CoV-2 specific antibody responses after the first and second dose of the BNT162b2 mRNA vaccine comparing the response of individuals with versus without abdominal obesity
Latest Information Update: 06 Dec 2021
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms VARCO-19
- 06 Dec 2021 New trial record
- 30 Nov 2021 Results published in the Obesity (Silver Spring, Md.)